• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2633
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Atrial Perforation (2511); Blood Loss (2597)
Event Date 02/19/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The 26 fr gore® dryseal flex sheath is intended for insertion into an external iliac artery with a minimum outside diameter of 9.5 mm, as it was reported the patient¿s right external iliac artery measured 6.5 ¿ 7.0 mm in diameter, the 26 fr sheath was oversized and therefore use was outside of ifu.
 
Event Description
The following information was reported to gore through the pivotal study for the gore® tag® thoracic branch endoprosthesis (tbe device): on (b)(6) 2018, the patient underwent endovascular treatment of a 55 mm descending thoracic aortic (zone 2) aneurysm, distal to the left common carotid artery ostium and proximal to the left subclavian artery, with two gore® tag® thoracic branch endoprostheses.According to the report, the left subclavian artery was the intended branch vessel to be treated.Successful access and delivery to the intended implantation site and retrieval of the device delivery system was reported.A spinal drain was reportedly placed to prevent paraplegia.Reportedly, during withdrawal of the 26 fr gore® dryseal flex sheath, minimal resistance was noted.It was reported, intra-operative imaging revealed the right external iliac artery, measuring 6.5-7.0 mm in diameter, had ruptured.The physician reported the iliac artery was minimally calcified and tortuous.Blood loss of 400 ml.Was reported and a transfusion of 500 ml of blood products was administered.According to the report, an iliac extender component and two gore® viabahn® endoprostheses were implanted into the right external iliac artery and the rupture was reported to have been resolved without sequelae.Final angiography confirmed exclusion of the aneurysm, repair of the rupture, and full patency of all devices.The procedure was concluded with no further adverse events reported and the patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7302989
MDR Text Key101163704
Report Number3007284313-2018-00073
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 02/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/07/2019
Device Catalogue NumberDSF2633
Device Lot Number17609964
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/07/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MEDICATIONS: CLOPIDOGREL AND ASPIRIN.
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age79 YR
Patient Weight82
-
-